Fujian Wanchen Biotechnology Group Revenue

Fujian Wanchen Biotechnology Group had revenue of 9.70B CNY in the quarter ending September 30, 2024, with 261.32% growth. This brings the company's revenue in the last twelve months to 25.01B, up 391.22% year-over-year. In the year 2023, Fujian Wanchen Biotechnology Group had annual revenue of 9.29B with 1,592.03% growth.

Revenue (ttm)

25.01B

Revenue Growth

+391.22%

P/S Ratio

0.51

Revenue / Employee

5.03M

Employees

4,972

Market Cap

14.06B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	9.29B	8.74B	1,592.03%
Jan 1, 2023	549.26M	114.56M	26.35%
Jan 1, 2022	434.70M	-15.28M	-3.40%
Dec 31, 2020	449.98M	-925.68K	-0.21%
Dec 31, 2019	450.91M	108.19M	31.57%
Jan 1, 2019	Pro	Pro	Pro
Jan 1, 2018	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Kweichow Moutai	165.20B
Contemporary Amperex Technology	365.28B
China Merchants Bank	293.75B
Ping An Insurance (Group) Company of China	940.90B
China Yangtze Power	86.59B
Midea Group	399.90B
Wuliangye Yibin Co.,Ltd.	88.65B
Foxconn Industrial Internet	583.90B

Revenue Rankings